Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients | MicrobiomeTrials← Back to trialsNCT05699018
Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2023-03-13Est. Completion: 2026-06-13
Enrollment target: 1,788 participants Locations- ANGERS, Angers, France
- CHU Angers, Angers, France
- BAUGE, Baugé-en-Anjou, France
- BECON, Bécon-les-Granits, France
- Chalonnes, Chalonnes-sur-Loire, France
- COMBOURG, Combourg, France
- LIFFRE, Liffré, France
- Montreuil, Montreuil-Bellay, France
- RENNES - Armagnac, Churchill, Rennes, France
- RENNES - Kennedy, Rennes, France
- CHU Rennes, Rennes, France
- SEGRE, Segré, France
- Val Couesnon, Val-couesnon, France
Other microbiome trials you might be interested in
Liver DiseaseFatty Liver
Background:
Metabolism refers to the many chemical pathways by which various compounds, including food, are processed a…
Bethesda, United StatesCompleted May 14, 2020
DiabetesFatty LiverObesityHealthy Volunteers
Background:
* Vitamin E is an antioxidant that reduces the damaging effects of oxygen in the body. Most American men (9…
Bethesda, United StatesCompleted Oct 21, 2016